History of Drug Development Solutions Center
| Year | Event |
|---|---|
| 1955 | Establishment of the first non-governmental radioisotope laboratory |
| 1963 | Release of the domestic-first radiopharmaceuticals |
| 1965 | Completion of construction of Tokai Laboratory |
| 1971 | Start of contract research business for pharmacokinetic study |
| 1975 | Completion of construction of the 2nd experiment facility, Tokai Laboratory |
| 1983 | Start of contract research business for antigenicity study Completion of construction of animal experiment facility, Tokai Laboratory |
| 1984 | Host of the 1st "Progress in Pharmacokinetics" seminar |
| 1985 | Completion of construction of the 3rd experiment facility, Tokai Laboratory Host of the 2nd "Progress in Pharmacokinetics" seminar |
| 1986 | The 1st MHW (the Ministry of Health and Welfare) GLP inspection for antigenicity study: rating "A" |
| 1987 | Host of the 3rd "Progress in Pharmacokinetics" seminar |
| 1989 | The 2nd MHW GLP inspection for antigenicity study: rating "A" |
| 1990 | Host of the 4th "Progress in Pharmacokinetics" seminar Completion of construction of the 4th experiment facility, Tokai Laboratory |
| 1993 | Host of the 5th "Progress in Pharmacokinetics" seminar The 3rd MHW GLP inspection for antigenicity study: rating "A" |
| 1995 | Start of contract research business for toxicokinetics study Host of the 6th "Progress in Pharmacokinetics" seminar |
| 1996 | Start of contract research business for pharmacokinetic study in compliance with the GLP standard |
| 1997 | The 1st OPSR (Organization for Pharmaceutical Safety and Research) GLP review for toxicokinetics study: rating "A" Host of the 7th "Progress in Pharmacokinetics" seminar |
| 1999 | Start of contract research business for human pharmacokinetic study using radio-labeled compounds Renamed "ADME & Tox. Research Institute" from the former Tokai Laboratory |
| 2000 | Memorial seminar for the 35th anniversary of the ADME & Tox. Research Institute The 2nd OPSR GLP review for toxicokinetics study: rating "A" |
| 2001 | Business alliance with RC Tritec AG (Synthesis of RI-labeled Compound) |
| 2003 | The 3rd OPSR GLP review for toxicokinetics study: rating "A" |
| 2004 | Business alliance with Institute of Accelerator Analysis Ltd. Business alliance with PhoenixBio Co., Ltd.（Studies using chimeric mice with highly humanized liver） |
| 2005 | Memorial seminar for the 40th anniversary of the ADME & Tox. Research Institute |
| 2007 | The 1st PMDA (Pharmaceutical and Medical Device Agency) GLP review for toxicokinetics study: rating "A" Business alliance with ICONIX Biosciences Inc. |
| 2008 | The company name was changed to "Sekisui Medical Co., Ltd." Memorial seminar for the establishment of Sekisui Medical Co., Ltd. |
| 2010 | The 2nd PMDA GLP review for toxicokinetics study: rating "A" Memorial seminar for the 45th anniversary of the ADME & Tox. Research Institute |
| 2011 | Business alliance with Korea Institute of Toxicology (Safety and enviromental study) |
| 2012 | The 3rd PMDA GLP review for toxicokinetics study: rating "A" |
| 2013 | The Economy, Trade and Industry Minister Award was given for "Development and Drug Discovery Technology by utilizing Microdose Clinical Studies" Business alliance with Curachem Inc. (Synthesis of RI-labeled Compound) |
| 2014 | Business alliance with Seoul National University Hospital and DCK consulting (Microdosing clinical study) Acquisition of AAALAC Full Approval by the Association for Assessment and Accreditation of Laboratory Animal Care International |
| 2015 | Host the 50th commemoration lecture meeting of the establishment of ADME&Tox. Research Institute The 4th PMDA GLP review for toxicokinetics study: rating "A" Conducting procuction of 14C-labeled API under GMP, and Japan's first mass balance study |
| 2016 | Name of Division and laboratory was changed to "Drug Development Solutions Division" and "Drug Development Solutions Center", respectively |
| 2017 | Renew AAALAC full accreditation |
| 2019 | Toxicokinetics study GLP Compliance Audit by PMDA; Qualified Name of the study facility was changed to Drug Development Solutions Center Business alliance with REPROCELL Inc. (In vitro studies using fresh human tissue) Business alliance with Axcelead Drug Discovery Partners Inc. (Marketing and promotion of drug discovery support services) |
| 2020 | Incorporate lab data management System (STARLIMS) Renew AAALAC full accreditation |
| 2021 | Incoporate electric data management System (SDMS) Business alliance with RINAT Imaging (Synthesis of RI-labeled nucleic acid compound) |
| 2022 | Toxicokinetics study GLP Compliance Audit by PMDA; Qualified Business alliance with BoZo Research Center （Safety Study) |
| 2023 | Business alliance with BioAgilytix (Biomarker Measurement） |
| 2024 | ISO14001＆45001 Integrated Certification Acquisition |